The safety of SGLT-2 inhibitors in diabetic patients submitted to elective percutaneous coronary intervention regarding kidney function: SAFE-PCI pilot study

Mateus Paiva Marques Feitosa, Carlos Serrano, Alexandre Abizaid et al.|Research Square|2023

Cited by 2